Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation-Reference-Cited by-同舟云学术

Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation

Published:2017-07 Issue:7 Volume:23 Page:1064-1071
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Getta Bartlomiej M.^ORCID,Devlin Sean M.,Levine Ross L.,Arcila Maria E.,Mohanty Abhinita S.,Zehir Ahmet,Tallman Martin S.,Giralt Sergio A.,Roshal Mikhail

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. The origin and evolution of mutations in acute myeloid leukemia;Welch;Cell,2012

2. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations;Lindsley;Blood,2015

3. Persistence of DNMT3A mutations at long-term remission in adult patients with AML;Ploen;Br J Haematol,2014

4. Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia;Klco;JAMA,2015

5. Assessment of minimal residual disease in standard-risk AML;Ivey;N Engl J Med,2016

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation;Transplantation Proceedings;2024-09

2. Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients;Transplantation and Cellular Therapy;2024-07

3. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors;Current Treatment Options in Oncology;2024-05-02

4. Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia;Leukemia Research;2024-05

5. Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia;Advances in Oncology;2024-05